KRAS Neoantigen Nanovaccine

· The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KRAS Neoantigen Nanovaccine, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer [Phase 1, Phase 2]